Feed VVOS
VV

Vivos Therapeutics, Inc.

VVOS · NASDAQ

$0.16 -4.13% (-$0.01)
1M -41.04%
Market Cap $2.22M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
100 /100
Cheap
P/S 0.11x
P/E N/A
EV/EBITDA N/A
Growth
34 /100
Stable
Rev. growth 2.87%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak
Gross margin 59.72%
Net margin 122.42%
Op. margin 107.92%
Quality
15 /100
Poor
ROIC 182.30%
ROA 105.97%
Asset turnover 0.87x
Debt
0 /100
High
Current ratio 0.21x
Int. coverage -22.30x
Debt/Equity N/A
Stability
38 /100
Moderate
Beta 6.00x
Rev. volatility 15.63%
EPS volatility 37.24%

Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe

Întreabă StockBot despre VVOS
Online

Despre companie

Vivos Therapeutics, Inc. (VVOS) is a company specializing in the treatment of sleep and breathing disorders, particularly obstructive sleep apnea. The company develops and commercializes therapeutic devices and solutions that assist patients with breathing difficulties during sleep. Vivos Therapeutics aims to improve sleep quality and patient health by focusing on strengthening the upper airway and enhancing ventilation. The company plays a pivotal role in the field of sleep medicine and respiratory disorders. Shares of Vivos Therapeutics, Inc. (VVOS) can be an interesting choice for investors tracking the healthcare sector and innovations in the treatment of sleep disorders.

Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.

Sector

Healthcare

Industry

Medical - Devices

CEO

R. Kirk Huntsman

Employees

268

Headquarters

Littleton

Evenimente viitoare

18 NOV.

Earnings

Upcoming earnings report

57d

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.